Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile-Associated Diarrhea in Hospitalized Patients

被引:45
作者
Aldeyab, Mamoon A. [1 ]
Harbarth, Stephan [2 ]
Vernaz, Nathalie [3 ]
Kearney, Mary P. [4 ]
Scott, Michael G. [4 ]
Funston, Chris [4 ]
Savage, Karen [4 ]
Kelly, Denise [5 ]
Aldiab, Motasem A. [6 ]
McElnay, James C. [1 ]
机构
[1] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast BT9 7BL, Antrim, North Ireland
[2] Univ Geneva Hosp & Med Sch, Infect Control Program, Geneva, Switzerland
[3] Univ Geneva Hosp & Med Sch, Dept Pharm, Geneva, Switzerland
[4] United Hosp Trust, Belfast BT42 2RL, Antrim, North Ireland
[5] Whiteabbey Hosp, Newtownabbey BT37 9RH, Antrim, North Ireland
[6] German Jordanian Univ, Sch Informat & Comp, Amman 11180, Jordan
关键词
PROTON-PUMP INHIBITORS; FLUOROQUINOLONE USE; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; DISEASE; EPIDEMIC; OUTBREAK; CLARITHROMYCIN; THERAPY; UPDATE;
D O I
10.1128/AAC.01214-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of this study was to evaluate the effects of antimicrobial drug use, gastric acid-suppressive agent use, and infection control practices on the incidence of Clostridium difficile-associated diarrhea (CDAD) in a 426-bed general teaching hospital in Northern Ireland. The study was retrospective and ecological in design. A multivariate autoregressive integrated moving average (time-series analysis) model was built to relate CDAD incidence with antibiotic use, gastric acid-suppressive agent use, and infection control practices within the hospital over a 5-year period (February 2002 to March 2007). The findings of this study showed that temporal variation in CDAD incidence followed temporal variations in expanded-spectrum cephalosporin use (average delay = 2 months; variation of CDAD incidence = 0.01/100 bed-days), broad-spectrum cephalosporin use (average delay = 2 months; variation of CDAD incidence = 0.02/100 bed-days), fluoroquinolone use (average delay = 3 months; variation of CDAD incidence = 0.004/100 bed-days), amoxicillin-clavulanic acid use (average delay = 1 month; variation of CDAD incidence = 0.002/100 bed-days), and macrolide use (average delay = 5 months; variation of CDAD incidence = 0.002/100 bed-days). Temporal relationships were also observed between CDAD incidence and use of histamine-2 receptor antagonists (H2RAs; average delay = 1 month; variation of CDAD incidence = 0.001/100 bed-days). The model explained 78% of the variance in the monthly incidence of CDAD. The findings of this study highlight a temporal relationship between certain classes of antibiotics, H2RAs, and CDAD incidence. The results of this research can help hospitals to set priorities for restricting the use of specific antibiotic classes, based on the size-effect of each class and the delay necessary to observe an effect.
引用
收藏
页码:2082 / 2088
页数:7
相关论文
共 35 条
[1]  
Akhtar AJ, 2007, J NATL MED ASSOC, V99, P500
[2]  
Al-Eidan FA, 2000, J CLIN PHARM THER, V25, P101
[3]   Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus:: a time-series analysis [J].
Aldeyab, Mamoon A. ;
Monnet, Dominique L. ;
Maria Lopez-Lozano, Jose ;
Hughes, Carmel M. ;
Scott, Michael G. ;
Kearney, Mary P. ;
Magee, Fidelma A. ;
McElnay, James C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) :593-600
[4]   Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile [J].
Apisarnthanarak, A ;
Zack, JE ;
Mayfield, JL ;
Freeman, J ;
Dunne, WM ;
Little, JR ;
Mundy, LM ;
Fraser, VJ .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :601-602
[5]   Narrative review: The new epidemic of clostridium difficile-associated enteric disease [J].
Bartlett, John G. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (10) :758-764
[6]   Case-control study of antibiotic use and subsequent Clostridium difficile -: Associated diarrhea in hospitalized patients [J].
Baxter, Roger ;
Ray, G. Thomas ;
Fireman, Bruce H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (01) :44-50
[7]   CLARITHROMYCIN AND PSEUDOMEMBRANOUS ENTEROCOLITIS [J].
BRAEGGER, CP ;
NADAL, D .
LANCET, 1994, 343 (8891) :241-242
[8]   Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis [J].
Cadle, Richard M. ;
Mansouri, Mohammad D. ;
Logan, Nancy ;
Kudva, Denise R. ;
Musher, Daniel A. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (22) :2359-2363
[9]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[10]   Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies [J].
Dial, S ;
Alrasadi, K ;
Manoukian, C ;
Huang, A ;
Menzies, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :33-38